CVS Health stock holds gains after UBS cuts target
Published on 09/10/2026 at 19:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
CVS Health Corp. (ISIN US1266501006) stock traded at USD 95.38 on September 9, 2026, with a market capitalization of USD 121.99 billion and a daily range of USD 92.79 to USD 98.29. UBS cut its price target to USD 118 from USD 126 on September 9, 2026, while keeping a Buy rating, and that keeps the focus on valuation after a strong quarter.
Guidance is the anchor
On September 10, 2026, CVS Health said it reported strong second quarter 2026 results and raised full-year 2026 guidance on its investor site, which is the key operating backdrop for the shares. MarketBeat said CVS posted USD 106.10 billion in revenue for the quarter, up 7.3 percent year on year, and adjusted EPS of USD 2.58, above the USD 1.87 consensus by USD 0.71.
That same source said CVS Health set FY 2026 EPS guidance at USD 7.90 to USD 8.10, while another market summary put the operating-cash-flow outlook at at least USD 11.5 billion. The comparison matters: revenue rose 7.3 percent, and EPS beat consensus by 37.8 percent.
Analysts stay active
Bernstein raised its CVS Health price target to USD 112 from USD 106 on September 10, 2026, while maintaining an Outperform rating, according to Investing.com. The same report said Bernstein cited a faster-than-expected Aetna turnaround and more cautious assumptions for health services because of 340B pricing pressure.
Wells Fargo kept a Buy rating and a USD 123 target, according to Moomoo. MarketBeat also showed a consensus target of USD 107.24 and a Moderate Buy rating, with 22 Buy ratings and 1 Hold rating in its overview.
Price near the range
The stock finished the session at USD 95.38 on September 9, 2026, which put it below MarketBeat's 52-week high of USD 110.68 and above its 52-week low of USD 69.51. Volume came to 3.71 million shares, versus an average of 8.24 million, and that leaves the recent move tied to the earnings reset rather than heavy trading.
CVS Health stock at a glance
- Company: CVS Health Corporation
- ISIN: US1266501006
- Ticker: CVS
- Trading venue: NYSE
- Price (as of September 9, 2026): USD 95.38
- Market capitalization: USD 122.05 billion (as of September 10, 2026)
- Sector / Industry: Healthcare / Healthcare Providers and Services
- Index membership: S&P 500
- Next earnings date: November 4, 2026
What investors watch
For investors, the key question is whether the raised 2026 outlook can offset the still-visible 340B pressure and the gap between the USD 95.38 close and the USD 107.24 consensus target. The stock also remains well below the USD 118 UBS target and the USD 123 Wells Fargo target.
